Inhalation Warnings For Aerosolized Antiperspirants Are Not Redundant – FDA
This article was originally published in The Tan Sheet
Executive Summary
The need for two inhalation warnings on labeling for aerosolized dosage forms in the OTC Antiperspirant Drug Products Final Monograph is justified, FDA says in a Feb. 17 letter to the Cosmetic, Toiletry & Fragrance Association